Clinical Trial Update: a Phase 1b/2a Study of JMT202 Injection in Participants With Hypertriglyceridemia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1b/2a study of JMT202 injection for hypertriglyceridemia is currently recruiting, sponsored by Shanghai JMT-Bio Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• JMT202

Snippet

Sponsor: Shanghai JMT-Bio Inc. | Conditions: Hypertriglyceridemia | Phase 1, Phase 2 | Status: RECRUITING